Mucinex Acquisition Nothing to Sneeze At

How can you keep pace with an accelerating marketing ecosystem? Join us at Brandweek Sept. 12–16 in Miami alongside leading CMOs, founders and change makers from GatoradeMarriottAlo YogaCampbell'sUncommon James and more. Book now.

Reckitt Benckiser’s increased marketing spend and acquisition of Adams Respiratory made for some healthy earnings for the first half of the year. RB reported that its net revenues increased 11% ($6.1 billion). Growth was driven by higher investment in RB’s 17 Powerbrands, including Lysol, Calgon and Woolite, as well as the successful rollout of Airwick Symphonia.

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in